Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

HealthVerity Joins Accenture’s INTIENT Network to Help Drive Innovation in Drug Discovery, Scientific Research and Improve Patient Outcomes

HealthVerity Joins Accenture's INTIENT Network to Help Drive Innovation in Drug Discovery, Scientific Research and Improve Patient Outcomes

HealthVerity, a leader in privacy-protected data exchange, has joined the INTIENT Network ecosystem which is designed to help independent software vendors (ISV) and life sciences companies collaborate more effectively to accelerate drug discovery efforts and improve patient outcomes.

As a member of the INTIENT Network, HealthVerity will join an elite group focused on providing the right data, at the right time, to the right team. The various players within the INTIENT Network are collaborating to apply artificial intelligence and advanced analytics to that dataโ€”delivering insights that can lead to better patient outcomes, faster than ever before.

The inclusion of HealthVerity’s technology and direct access to its expansive healthcare data ecosystem provides life sciences and healthcare companies with three differentiating benefits through the INTIENT Platform.

With the deployment of HealthVerity Census, a leading patient identity resolution technology, INTIENT clients will have the ability to accurately de-identify and match their own proprietary data on-demand for enhanced interoperability and privacy, whether in their own environment or within INTIENT.

INTIENT clients will have access to HealthVerity Marketplace, the largest healthcare data ecosystem in the US. Encompassing more than 330 million patients and 150 billion transactions, life sciences and insurance companies can discover and license healthcare and consumer data for immediate delivery through the platform. Furthermore, because of the power of Census, all HealthVerity Marketplace data is readily interoperable with patient or member-level proprietary client data.
For social determinants of health, HealthVerity Cipher will offer clients the ability to run HIPAA-compliant analytics on combinations of healthcare data and consumer data to yield unique socio-economic and demographic insights about cohorts of interest.

“The three technology pillars of HealthVerity including de-identification, discovery and linkage, when paired with INTIENT’s world-class patient analytics platform, will deliver a tremendous competitive advantage in the race to address the world’s most important health challenges,” said Andrew Goldberg, COO of HealthVerity. “By combining data that had not been combined before, we are offering INTIENT clients an opportunity to glean new insights and we’re excited to collaborate with Accenture to see this concept come to life.”

“We are pleased to welcome HealthVerity to the INTIENT data ecosystem,” said Derek Pollock, managing director at Accenture. “We believe that HealthVerity fills an important role in demonstrating value and innovation we can create for our clients. By accelerating the discovery and consolidation of disparate patient data in a HIPAA-compliant manner, INTIENT can now further enhance the types of analytics that will yield insights about patients that will foster new therapies, patient experiences and better outcomes.”

About HealthVerity
For transformative, evidence-led healthcare companies, HealthVerity enables the creation and execution of unique end-to-end data strategies with privacy and HIPAA-compliance at the forefront. With HealthVerity technologies directly embedded into the enterprise workflow and the largest, most flexible data ecosystem at their fingertips, our partners benefit from cloud solutions spanning expert patient identity resolution to secure data management and transformation.

GE Healthcare acquires Swedish developer of CT image-boosting photon detectors

GE Healthcare acquires Swedish developer of CT image-boosting photon detectors

GE Healthcare has moved to acquire a Swedish startup and its next-generation photon-counting technology, which the medtech manufacturer says could help expand the clinical reach of its CT scanners.

Prismatic Sensors has developed sensitive detectors capable of reading individual beams of X-ray energy, at a rate of hundreds of millions of photons per second. Their design aims to eliminate the extra electronic noise in a scan, ultimately lowering the overall dose of radiation received by a patient while improving the quality of the image.

Dubbed Deep Silicon technology, this would allow for higher-resolution visualizations of more minute details in organs and tissuesโ€”such as pictures of smaller blood vessels or malignant cells, and more accurate density measurementsโ€”with potential applications across cancer care, cardiology, neurology and more.

โ€œWe believe this technology has the potential to be a substantial step forward for CT imaging to establish a new standard of care and eventually improve clinical outcomes for millions of patients worldwide,โ€ GE Healthcare President and CEO Kieran Murphy said in a statement.

GE researchers first began studying photon-counting technology in 1993 and launched the worldโ€™s first prototype using cadmium-based detectors in 2006. Now, GE said Prismaticโ€™s Deep Silicon detectors promise a better solution to the high levels of energy produced by CT imaging, and are capable of providing more information to clinicians.

โ€œSilicon is by far the purest material produced for use in detectors,โ€ said Prismatic CEO Mats Danielsson. โ€œAlternative materials, including cadmium-based, will be limited as X-ray detector materials due to their imperfect crystal structure and contaminations. Silicon-based detectors will enable superior spectral resolution without compromising on count rate or spatial resolution.โ€

GE has held a minority position in the company since 2017, which was originally founded in 2012 as a spin-off from the KTH Royal Institute of Technology in Stockholm. The two companies aim to close the deal by January 2021; the transactionโ€™s financial terms were not disclosed.

Penumbra’s Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism

Penumbra's Newest Generation of Indigo Aspiration System Receives FDA Clearance for Pulmonary Embolism

Penumbra, Inc., a global healthcare company focused on innovative therapies, announced U.S. FDA clearance for expanded indication of the latest iteration of the Indigoยฎ Aspiration System, Lightning. As part of the Indigo Aspiration System, Lightning 12 (Indigo System CATโ„ข 12 Aspiration Catheter with Lightning Intelligent Aspiration) and Separator 12 are now indicated for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems as well as for the treatment of pulmonary embolism.

Pulmonary embolism, or PE, is a deadly condition causing blood clots within a patientโ€™s lungs that has grown in prevalence during the COVID-19 pandemic. The Indigo Aspiration System with Lightning 12 removes these difficult-to-access, life-threatening clots, potentially reducing the need for thrombolytics and their associated ICU stays.

โ€œPenumbra continues to strive to bring innovative therapies to the medical community, and this is another important milestone that will help advance pulmonary embolism intervention,โ€ said Adam Elsesser, president and chief executive officer, Penumbra. โ€œCOVID has increased the awareness of the need for therapies that remove blood clots, and we are thrilled with the FDA clearance of the PE treatment indication for Lightning 12.โ€

The Indigo System Lightning 12 is the companyโ€™s newest generation aspiration system for peripheral thrombectomy. Lightning 12 combines the Indigo System CATโ„ข12 Aspiration Catheter with Lightning Intelligent Aspiration, enabling physicians to focus on optimizing thrombus removal using the systemโ€™s unique clot detection mechanism. CAT12 is a large-lumen aspiration catheter that incorporates novel laser-cut hypotube-based catheter engineering to provide advanced deliverability and torqueability within the body. This combination of intelligent aspiration and large-lumen catheter engineering makes Lightning 12 Penumbraโ€™s most advanced clot removal technology for the treatment of pulmonary embolism.

The Indigo System Lightning 12 was launched in July and is available immediately for patients needing interventional treatment for PE.

About Pulmonary Embolism

Pulmonary embolism (PE) is a condition that occurs when blood clots, typically traveling from the veins in the legs, get caught in the arteries of the lungs. Blood clots in the lungs can block the lungs from absorbing oxygen, causing strain on the heart and other organs. According to the American Heart Association, PE affects roughly 367,000 Americans per year.1

About Indigo System

The latest generation of Penumbraโ€™s continuous aspiration thrombectomy system features Indigo System Lightning 12 which combines the new Indigo System CAT 12 Aspiration Catheter with Lightning Intelligent Aspiration powered by Penumbra ENGINE, enabling physicians to focus on optimizing thrombus removal using the systemโ€™s unique clot detection mechanism. The Indigo Systemโ€™s proprietary Separator technology, Separator 12 is also available with Lightning 12 and is designed to enable unobstructed aspiration for the duration of the procedure. Lightning 12 and Separator 12 are designed for the removal of fresh, soft emboli and thrombi from the peripheral arterial and venous systems, and for the treatment of pulmonary embolism.

In addition to Lightning 12, the Indigo System also now includes Lightning 8 which combines the Indigo System CAT 8 Aspiration Catheter with Lightning Intelligent Aspiration for the removal of fresh, soft emboli and thrombi from the peripheral arterial and venous systems, and for the treatment of pulmonary embolism. Lightning 12 and Lightning 8 expand the already broad offering of CAT8, CATD, CAT6, CAT5, and CAT3 and are paired with Penumbra ENGINE, the companyโ€™s proprietary continuous, mechanical vacuum aspiration pump.

About Penumbra

Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra sells its products to hospitals and healthcare providers primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets.

Moses 2.0: Improving the Gold Standard for Laser Lithotripsy

The gold standard of laser lithoprisy is the holmium laser. The technology has advanced incrementally through several generations in a way thatโ€™s very similar to developments in mobile phones, in that each generation provides users with greater speed and versatility. MOSES technology marked the fourth-generation holmium laser system, and now MOSES 2.0 continues to enhance gold-standard therapy.

MOSES elevated the holmium laserโ€™s capabilities โ€”MOSES technology (Lumenis) is a platform that manipulates the holmium laser waveform, as well as the first technology to deliver holmium energy over two pulses. The approach allows MOSES to deliver more energy to the stone, achieve finer fragmentation, and produce less retropulsion, which improves visualization and spontaneous stone clearance for laser lithotripsy.

In a laboratory study, we showed that the MOSES distance mode yielded 28% greater fragmentation than the standard short-pulse holmium mode when in contact with the stone, as well as 100% more fragmentation when the fiber is 1mm from the stone.1 This is important clinically when we use a dusting technique. During dusting, only 23% of laser pulses are delivered within 0.5mm of the stone, while 48% happen at a distance greater than 1mm.2 Because MOSES is optimized for contact and distance, it is an efficient choice. In a recent clinical trial, MOSES reduced fragmentation time 32% and procedure time 20% compared to standard holmium.3

Another factor is that the distance reach of MOSES pulse reduces creation of large fragments during the popcorn techniqueโ€”an important endpoint because residual fragments greater than 2mm are associated with repeat surgery.4ย  In my experience, the MOSES laser is also particularly useful in mini-PCNL because it leads to faster treatment of larger stones, less retropulsion and less bleeding, allowing me to perform a tubeless technique.

MOSES 2.0 continues the holmium evolution โ€”With the development of high-frequency holmium lasers, we wondered how much frequency is actually required for effective fragmentation, as well as how the combination of frequency and fiber speed affects fragmentation. In a recent laboratory study, we found that a moving laser fiber maximizes the frequencyโ€™s usefulness. By increasing the fiber speed from 1mm/sec to 3mm/sec (MOSES distance mode), ablation was increased by 140%. 5High-speed imaging analysis showed that 15 pulses could be applied to a single location for maximum effect. If the fiber was moving at 1mm/sec, this equated to a frequency threshold around 62 Hz. If the fiber is moving 2mm/sec, we can increase that threshold to 123 Hz.

The ability to use 120 Hz is now a reality with the launch of MOSES 2.0. Using the MOSES 2.0 120 Hz laser with a faster painting motion increases fragmentation speed and may be more efficient for pop-dusting as well. Optimized photothermal ablation at contact and distance allows the surgeon to work more efficiently. The end result is shorter procedure time, as well as potential the ability to avoid staged procedures for large kidney stones treated with ureteroscopy.

MOSES holmium lasers have staying power โ€” Getting laser lithoprisy โ€œjust rightโ€ requires a careful balance of material absorption, fluid absorption and safety. The MOSES 2.0 holmium laser is the gold standard of laser lithoprisy because it gets that balance just right. In contrast, the thulium fiber laser has a high fluid absorption, which may prevent efficient ablation at distance, while its excessive long pulse duration may lead to photothermal collateral damage if using high power settings. MOSES 2.0 has optimized photothermal ablation at contact and distance, improving the efficiency of laser lithoprisy.

Reference

1. Aldoukhi AH, Roberts WW, Hall TL, Ghani KR. Watch Your Distance: The Role of Laser Fiber Working Distance on Fragmentation When Altering Pulse Width or Modulation. J Endourol. 2019 Feb;33(2):120-126.
2. Aldoukhi AH, Black KM, Hall TL, et al. Defining Thermally Safe Laser Lithotripsy Power and Irrigation Parameters: In Vitro Model. Endourol. 2020 Jan;34(1):76-81.
3. Ibrahim A, Elhilali MM, Fahmy N, Carrier S, Andonian S. Double-Blinded Prospective Randomized Clinical Trial Comparing Regular and Moses Modes of Holmium Laser Lithotripsy. J Endourol. 2020 May;34(5):624-628.
4. Black KM , Aldoukhi AH, Teichman JMH, et al. Pulse modulation with Moses technology improves popcorn laser lithotripsy. World J Urol. 2020 Jun 6.
5. Aldoukhi AH, Black KM, Hall TL, Roberts WW, Ghani KR. Frequency Threshold for Ablation During Holmium Laser Lithotripsy: How High Can You Go? J Endourol. 2020 Oct;34(10):1075-1081.

Why You Should Listen To Your Body While Losing Weight

There are a series of factors to be considered when one attempts to lose weight. However, before diving into the details, letโ€™s primarily define body weight. Basically, our bodies are composed of fat, lean body mass, and water. These proportions vary for each individual. Factors such as gender, age, and lifestyle affect what constitute our total weight. In fact, Barbara J. Moore, PhD, president of Shape Up! America, said that women can and should weigh heavier than men. This is due to their different reproductive functions. In order to support that purpose, women should hold higher fat in their bodies.

When you try to shed off weight, itโ€™s crucial to examine and ask yourself how you would approach this undertaking. Itโ€™s important to be strategic and to carefully consider โ€œadviceโ€ from others. The Internet, fitness gurus, and people in general might offer different suggestions on how you should deal the process. However, itโ€™s more sustainable to visualize matters for yourself so youโ€™ll have an easier time self-regulating and steering your way through obstacles.

Moreover, before you begin your weight-loss journey, you need to primarily educate yourself onย  what is body composition. This knowledge is important because this will aid you in evaluating your health and your current fitness level. Itโ€™s also essential to bear in mind that weighing yourself on a scale will not accurately depict your body composition.

Why Do People Want to Lose Weight?

Interestingly, people have different reasons for desiring to lose weight. Some may need to do it due to health-related conditions, while others are required to because itโ€™s part of their job. Athletes, cabin crew members, and certain professional models have a weight requirement to adhere to.

Likewise, there are those who want to lose weight for aesthetic reasons, such as looking lean or maintaining their physique. Thereโ€™s nothing wrong with this if you pursue it for the right purpose. For instance, if it boosts your self-confidence and allows you to be flexible in accomplishing more goals, then no one should stop you. No one should be shamed or discriminated against for their personal reasons for wanting to be fit. What matters is listening to your body to make weight-loss work for you.

Why Should We Listen to Our Body While Losing Weight?

  1. Our Bodies Are Different

Humans in general tend to appreciate, desire, and become mesmerized with bodily aesthetics. The โ€œideal physiqueโ€ is often glorified by the entertainment and fitness industries, and society seems to celebrate when people shed off a few pounds as evidenced by shows like The Biggest Loser.

Because of these, thereโ€™s a gradual buildup of external pressure to lose weight fast, thus causing people to set up their fitness journeys with unrealistic strategies and expectations. However, the truth is that some individuals may shed weight quicker than othersโ€”and this is completely normal.

Each body type is unique, and a personโ€™s genetic inheritance impacts their body shape, size, bone structure, and weight.

Although some may attempt to emulate fitness gurus by eating the same food and exercising in the same duration, their body would still not turn out exactly the same as these gurus. Hence, itโ€™s essential to listen to your body and be rational with your approach.

Keep in mind that there should be harmony among your food, physical activity, and mental health. When you have balance among the three, then this may allow you to overcome any weight-loss hurdles along the way.

  1. Our Bodies are the Best Sources of Information

Our bodily sensations are one of the best sources of information. These were intended for a purpose and are crucial to tune in to.

While on the process of weight loss, your body will prompt you with physical signs that you need to attend to. Such examples are when youโ€™re at the brink of experiencing burnout, need to fuel yourself, are overwhelmed, exhausted, and the like. These feelings should primarily be regarded and validated, not set aside.

Unfortunately, most of us can be too preoccupied with our weight-loss goals and directly push past these cues. This brings more harm than good. When you dismiss your bodily signals, this may be amplified through detrimental stress, as well as certain sicknesses and diseases. Hence, itโ€™s essential to pay attention your bodyโ€™s concerns while attempting to lose weight.

  1. Our Bodies Are Smart

Through its own feedback systems and self-regulation, your body is able to function independently from the mind. If you pay attention to it, then youโ€™ll know when somethingโ€™s off or if you need to extend your recovery period.

While sailing along this weight-loss journey, you need to recognize that your body is smart and you need to trust its manifestations. Your body was programmed to have its distinct boundaries, which are not meant to limit but to protect. This allows you to assess how far you can go before you drain yourself. It exists as a reminder that youโ€™re human and not a machine.

  1. Our Bodies Will Help Us With Our Goals

Ultimately, itโ€™s important to establish rapport with your body. This will help you extend empathy and patience towards its weight-loss progress. In turn, when you learn to be attentive to it, then your body will assist you further as you move and would cooperate more as you progress towards your fitness goals.

Awareness with your body is essential because this will enhance your experience with exercise. Significantly, apart from aiming for weight loss, this journey should teach be able to teach you to improve your relationship with your body.

Moreover, listening to your body can help you approach weight loss with the right mindset. This can help alleviate stress, maintain mental health, and promote a healthy perspective with food and exercise.

Losing Weight: A Nonlinear Journey

It is neither sustainable nor healthy to rush the process of losing weight. It is also impractical to solely fixate on this objective. Due to stress and pressure, most of us may no longer appreciate activities such as exercise and food preparation. We might no longer take moments to acknowledge our mini wins and progressions.

The pursuit towards weight loss should supposedly be nonlinear. There will be trial and errors along the way. Itโ€™s a journey of making amends and getting to know our bodies. Itโ€™s also a process of acknowledging how privileged we are as we engage in this undertaking.

Takeaway

There will be times when tuning into your body will become a challenge. This may be due to the external distractions, such as various information and tips from people โ€œwho have been there.โ€ Remember to only pick up lessons that are useful.

Amid the noise, take time to pause and pay attention to your bodyโ€™s cues. Learn to loosen up and appreciate the journey, no matter where youโ€™re currently at. Lastly, when you learn to trust your body, it may perhaps gradually find balance on its own.

What You Need to Know About Hair Serums

What You Need to Know About Hair Serums

Hair loss is one of the common problems that millions of men and women have to suffer. This is why it is fairly common to see many products in the market aiming to provide hair loss solutions. Among those that are growing in popularity are serums like CL Activating Serum, which promote hair health. If you are new to hair growth serums, here are some things you should know about before you start using them:

Will Hair Serums Make Your Hair Grow?

Genetics play a huge role in determining hair regrowth rate, which varies from one person to another. You also have to keep in mind that various factors contribute to a personโ€™s hair loss. Usually, hair loss can be due to hormonal changes, specifically after giving birth, or it can also be due to stress. In these cases, the hair follicles are often too damaged even to produce new hair growth, and this process is often irreversible. You cannot use hair serums alone to encourage hair growth, but they can promote the health of hair follicles.

What Are the Uses of Hair Serums?

While hair serums will not make your hair grow back, they have tons of other benefits:

Repairs Damaged Hair

Hair serums have been proven to repair damaged hair. They can tame frizz and flyaways by nourishing hair follicles, giving it a fuller and thicker volume. They can also prevent the spread of split ends that can weaken hair strands. Most hair serums have oils and extracts that condition hair, repair dead skin cells, and improve blood flow to the scalp. They are great for giving the hair an enviable luster. Serums can also provide a protective sheath to lock in moisture and fight the adverse effects of styling ingredients and tools.

Improves Hair Growth Cycle

Hair serums will never make your hair grow back, but they can help improve the hair growth cycle of hair follicles. When this cycle is working correctly, you will notice a significant reduction in hair loss. Activating serums can help stimulate dermal papilla cells that are significant in regulating hair follicle development and growth. Furthermore, hair serums are critical in blocking the activity of 5 alpha-reductase, which contributes to hair loss.

Keeps Hair Healthy

If you want to keep your hair healthy and strong, hair serums can be useful in promoting this. They have ingredients enough to give nourishment to your scalp and promote healthy hair. You would notice that the longer you use them, the hair becomes glossier, signaling good health.

What Are the Ingredients of Hair Serums?

Hair serums are usually a mix of essential oils, phytoextracts, biotin, and a number of bioactive ingredients such as coconut oil, natural extracts, zinc, and amino acids. When all of these ingredients work together, users can notice significant changes in their hair health.

How Do You Effectively Use Hair Serums?

  • If you want to get maximum results, you have to effectively use hair serums. Hereโ€™s how:
  • You should use hair serums after washing your hair. While it is still wet, take two to five drops of the hair serum.
  • Apply it on areas where there is hair thinning. Massage it using in a circular motion so the scalp would completely absorb it.
  • Do this routine at least two to three times a week.

Promoting hair health should be part of your routine if you want to make sure that you wonโ€™t have any bald spots. For those with a genetic predisposition to hair loss, it helps to follow a healthy diet and remove any potential stressors that can further cause hair loss.

NIH awards $45 million to expand research to improve COVID-19 testing among underserved and vulnerable populations

NIH awards $45 million to expand research to improve COVID-19 testing among underserved and vulnerable populations

The National Institutes of Health (NIH) has awarded nearly $45 million to expand the research network of the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) programme, adding 20 institutions and seven states and territories.

RADx-UP aims to enable and enhance COVID-19 testing of populations disproportionately affected by the disease, including African Americans, American Indians/Alaskan Natives, Latinos/Latinas, Native Hawaiians, older adults, pregnant women and those who are homeless or incarcerated. This second round of awards brings the total investment in the RADx-UP programme to more than $283 million at 55 institutions across 33 states and territories and the Cherokee Nation.

These new grants bolster two critical components of the RADx-UP programme to address testing hesitancy among underserved and/or vulnerable populations:

Research on the 1) cultural, ethical, social, behavioral, historical, economic and contextual factors associated with COVID-19 testing; 2) attitudes, expectations and preferences for testing and how test results influence ability and willingness to get tested; 3) interpersonal, institutional (e.g., health system), community and policy factors that affect access to COVID-19 testing.

A collaborative network of community-engagement projects with established programs that have adequate capacity, infrastructure and relationships with underserved communities. This effort will strengthen available data on disparities in infection rates and disease progression and outcomes and improve understanding of differences in testing access and uptake patterns.

The initial round of awards announced on September 30, 2020 also includes a coordination and data collection center at Duke University, Durham, North Carolina.

The Rapid Acceleration of Diagnostics (RADxSM) initiative was launched on April 29, 2020, to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing. The initiative has four programs: RADx Tech, RADx Advanced Technology Platforms, RADx Underserved Populations and RADx Radical. It leverages the existing NIH Point-of-Care Technology Research Network. The RADx initiative partners with federal agencies, including the Office of the Assistant Secretary of Health, Department of Defense, the Biomedical Advanced Research and Development Authority, and US Food and Drug Administration.

The National Institutes of Health (NIH), the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the US Department of Health and Human Services.

Invicta Health Solutions Pledges Sustainability Commitment

Invicta Health Solutions Pledges Sustainability Commitment

Invicta Health Solutions, a Houston-based, minority-owned provider of specialized technology and revenue cycle services for hospitals and health systems, recently unveiled its commitment to standards of Sustainability.

As an employer committed to diversity, equity & inclusion, Invicta hires and retains employees with varied backgrounds, ethnicity and life experiences. Invicta employs a US-based workforce comprised of multi-generational, ethnically diverse talent and a sophisticated patient outreach program led by a client-facing team, at present, 50% of whom are Spanish-language speakers. The Companyโ€™s personnel headcount has quadrupled since June of this year, with a turnover rate of just under 1.5% – positively against trend for a traditionally high turnover field.

Invictaโ€™s Chief Executive Officer, Donny Zamora, made comments from the organizationโ€™s corporate headquarters in Houston, Texas.

โ€œInvictaโ€™s leadership team aggressively cultivates a culture and environment that will support a largely mobile staff supporting hospital clients in markets around the U.S. Revenue cycle management services companies, as an industry, are not necessarily heralded for progressive employee engagement best practices. Plainly, we want to be the pace-setter. We know our approach also benefits our external stakeholders, clients and the communities in which we live, work and do business. Part of that expression is a clear commitment to sustainable practices.โ€

Operationally, Invicta evaluated sustainable best practices that could be deployed with their business model and subsequently landed on simple yet meaningful standards to reduce its carbon footprint โ€“ many of which were already in place, illustrating the innate and natural social and economic best practices that develop in such organizations.

Derek Shaw, Division President of the Company and its internal technology visionary, spoke to Invictaโ€™s role as a Revenue Cycle Management company leading the movement of sustainability in healthcare.

โ€œTechnology-forward businesses, whether they specialize in revenue cycle management as we do, or some other field, have a responsible role to advance sustainable practices. The cornerstone of creativity in any form of innovation stems from the core human desire to improve and augment the world that our children will inherit.โ€

Earlier this month, Invicta also launched its community service platform, InvictaSERV, with a goal of volunteering with food bank and food insecure service programs in the 11 markets around the United States where employees live as the holiday season activation.

Zamora explained the passion behind the executive teamโ€™s laser focus on internal culture.

โ€œInvicta Health Solutions operates with a singular mission: utilize advanced technology to revolutionize the way hospitals and health systems effectively manage critical components of the revenue cycle. In the midst of the global pandemic, our brand has flourished because we have integrated Guiding Principles that attract and cultivate discerning talent, customer-centric engagement and technology solutions to benefit the end recipients of our work โ€“ patients and their families. We know there is an intrinsic connection between productive, happy employees and forward-thinking business practices.โ€

About Invicta Health Solutions

Invicta Health Solutions, a US-based, minority-owned organization, partners with healthcare organizations to provide meaningful solutions for improved operational and financial performance–all while positively impacting patientsโ€™ satisfaction. Invicta Health Solutionsโ€™ approach combines advanced technology, proven workflows, and a dedicated team of healthcare professionals to consistently exceed customersโ€™ expectations.

Encompass Group Introduces the COVAIRE Clear Barrier Drape to Further Protect Health Providers from COVID-19 Spread During Aerosol-Generating Procedures

Encompass Group Introduces the COVAIRE Clear Barrier Drape to Further Protect Health Providers from COVID-19 Spread During Aerosol-Generating Procedures

Encompass Group, LLC, a leading manufacturer and marketer of reusable textiles, professional apparel, and disposable and single-use medical products, announces theย COVAIREโ„ข clear barrier drape, an innovative new product that helps contain viral aerosols using a clear plastic disposable barrier.

For healthcare providers, the single-useย COVAIREย is the only PPE that is specifically designed to be the most simple and effective additional barrier to further protect providers from pathogen exposure โ€“ including COVID-19 โ€“ during and after aerosol-generating procedures, such as intubation and extubation, offering a new element to strengthen the essential PPE protocol.

Recent studies from the New England Journal of Medicine have proved that once aerosolization occurs, airborne particles containing the live COVID-19 virus may be suspended in the air for up to three hours, increasing the risk for healthcare worker exposure. According to the American College of Cardiology, 10.7 percent of clinicians in a multinational cohort exposed toย COVID-19 during intubation either confirmedย COVID-19 diagnosis or had symptoms that required self-isolation. This increased risk to healthcare providers has made it necessary to redefine the standards for protection, and to find protection that works especially during aerosol-generating procedures.ย COVAIREย is a new part of the essential PPE toolkit for all providers; it is easy to stock and to use, allows full range of motion to treat patients, and redefines the required standard of protection for health providers.

Kristy Warren MSN-Ed, RN, BA, CLLM, the Director, Clinical Resources atย Encompass Group, LLC says, “With the coronavirus crisis, there is an increased focus on finding ways to further protect healthcare workers and operating room personnel from exposure to COVID-19. With the significant increased risk from aerosol generating procedures, such as intubation, extubation, TEE, CPR, and EGD, care providers need more assurance that they have the best protection possible.ย COVAIREย adds the extra layer of protection health workers need, and should be considered as part of the new standard PPE protocol.”

COVAIREย is made of a clear, medical grade film that is comfortable, and lightweight, and is specially designed to fit on even bariatric patients and not move during use. A curved opening on each side allows the provider to insert their arms for a full range of movement without restriction when operating an apparatus, intubating, or extubating. Once a procedure is complete,ย COVAIREย folds up, aerosolized viral particles are contained in the drape and the product can be easily and safely disposed of.

COVAIRE’s cost-effective, small individual package size allows it to be stored in quantity for easy access in code, respiratory, and anesthesia carts. It can be used in all patient care areas: OR, ICU, ED, In-patient, Outpatient, and Cardiology.

About Encompass Group

Encompass is one of the world’s leading manufacturers and marketers of reusable textiles, professional apparel, and disposable and single use medical products. Encompass believes that every patient, resident,ย caregiver, and family member should feel safe and comfortable in today’s healthcare environments. The way Encompass enhances the healthcare experience is by developing innovative products that are reliably delivered and cost effective for all providers.

Lantheus Holdings, Inc. Announces FDA Approval of DEFINITY Room Temperature

Lantheus Holdings Announces FDA Clearance for AI-Enabled Automated Bone Scan Index in Prostate Cancer on GE Healthcare's Xeleris Platform

Lantheus Holdings, Inc. , the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, announced the U.S. FDA has approved the supplemental new drug application (sNDA) for DEFINITYยฎ Room Temperature (DEFINITY RT) (Perflutren Lipid Microsphere) Injectable Suspension.

โ€œWith the approval of DEFINITY RT, we expand our microbubble franchise offering to include a room temperature formulation, in addition to our market leading, refrigerated DEFINITY that our customers and patients have trusted to enhance suboptimal echocardiograms for 19 years. This approval will enable those customers who prefer a non-refrigerated product to be able to continue to benefit from our DEFINITY microbubble products,โ€ said Paul Blanchfield, Chief Commercial Officer.

Mary Anne Heino, President and Chief Executive Officer, added, โ€œWe continue to expand the offerings in our microbubble franchise. The addition of DEFINITY RT recognizes the increasing need for portability in delivery of healthcare services, as well as our commitment to partnering with innovators developing complex product formulations which include a microbubble. I am thankful to the entire Lantheus team who worked diligently to bring this new formulation to the market.โ€

DEFINITY RT is a modified formulation of DEFINITY that allows both storage and shipment at room temperature (DEFINITYโ€™s previously approved formulation requires refrigerated storage). The activation of DEFINITY RT will be achieved using the VIALMIXยฎ RFID device, which was approved in August 2020. This modified formulation provides clinicians an additional choice and allows for greater utility of this formulation in broader clinical settings.

About DEFINITYยฎ and DEFINITYยฎ RT

DEFINITY Vial for Injectable Suspension and DEFINITY RT (Perflutren Lipid Microsphere) Injectable Suspension (activated) are ultrasound enhancing agents for use in patients with suboptimal echocardiograms. DEFINITY and DEFINITY RT are engineered to produce small and consistently sized durable microbubbles to fully evaluate the left ventricle. DEFINITY has extensive safety experience and a consistent safety profile. Since its launch in 2001, more than 14 million echo studies have been performed with DEFINITY, and it is the most prescribed ultrasound enhancing agent in the U.S.

Translate ยป